Bridgebio Oncology Therapeutics, Inc. (BBOT)
2.04
-0.13
(-5.99%)
USD |
NASDAQ |
Nov 06, 16:00
2.08
+0.04
(+1.96%)
After-Hours: 20:00
Bridgebio Oncology Therapeutics EPS Diluted (TTM) : -1232.83 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1232.83 |
| March 31, 2026 | -1094.09 |
| December 31, 2025 | -622.20 |
| September 30, 2025 | -1697.27 |
| June 30, 2025 | -1696.98 |
| March 31, 2025 | -1130.43 |
| Date | Value |
|---|---|
| December 31, 2024 | -1076.15 |
| September 30, 2024 | -0.598 |
| June 30, 2024 | 0.1387 |
| March 31, 2024 | 0.0446 |
| December 31, 2023 | -0.0022 |
| December 31, 2022 | -0.0002 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Korsana Biosciences, Inc. | -11.76 |
| IRulya Therapeutics, Inc. | -125.60 |
| PepGen Inc. | -1.306 |
| Q32 Bio, Inc. | 3.343 |
| Arrowhead Pharmaceuticals, Inc. | -2.243 |